Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices

被引:71
|
作者
Skene, DJ [1 ]
Papagiannidou, E [1 ]
Hashemi, E [1 ]
Snelling, J [1 ]
Lewis, DFV [1 ]
Fernandez, M [1 ]
Ioannides, C [1 ]
机构
[1] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
CYP1A2; cytochrome P450; enzyme induction; liver slices; melatonin; 6-sulphatoxymelatonin;
D O I
10.1034/j.1600-079X.2001.310408.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present studies was to define the enzyme systems catalysing the 6-hydroxylation of melatonin, by monitoring the levels of 6-sulphatoxymelatonin in rat hepatic postmitochondrial preparations and in precision-cut liver slices. Melatonin 6-hydroxylase activity was localized in microsomes and was supported by NADPH, but not NADH. Treatment of rats with beta -naphthoflavone more than tripled 6-sulphatoxymelatonin formation from melatonin, but gave rise only to a moderate increase (25%) in the sulphate conjugation of 6-hydroxymelatonin. Treatment of rats with phenobarbitone, acetone, dexamethasone and clofibrate did not increase 6-sulphatoxymelatonin generation when either melatonin or 6-hydroxymelatonin served as substrates. Of a number of cytochrome P450 inhibitors investigated, only furafylline inhibited markedly the conversion of melatonin to 6-sulphatoxymelatonin without any concomitant effect on the sulphoconjugation of 6-hydroxymelatonin. When liver slices were incubated with melatonin, treatment of rats with beta -naphthoflavone, and to a lesser extent phenobarbitone. elevated the levels of 6-sulphatoxymelatonin in the culture medium. No such increase was seen when slices from beta -naphthoflavone-treated rats were incubated with 6-hydroxymelatonin, whereas a modest increase was seen with slices from phenobarbitone-treated rats. Treatment of rats with acetone, dexamethasone or clofibrate railed to modulate the levels of 6-sulphatoxymelatonin generated from either melatonin or 6-hydroxymetatonin. Molecular modelling analysis revealed that melatonin had a high area/depth(2) ratio, displayed characteristics of CYP1A2 substrates and could be readily accommodated into the human CYP1A2 active site in a position favouring 6-hydroxylation. Collectively, all the above data provide strong experimental evidence that CYP1A2 is an important catalyst of the 6-hydroxylation of melatonin.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [21] EXPRESSION OF CYP1A1 AND CYP1A2 GENES IN HUMAN LIVER
    SCHWEIKL, H
    TAYLOR, JA
    KITAREEWAN, S
    LINKO, P
    NAGORNEY, D
    GOLDSTEIN, JA
    PHARMACOGENETICS, 1993, 3 (05): : 239 - 249
  • [22] Delayed ontogenesis of CYP1A2 in the human liver
    Sonnier, M.
    Cresteil, T.
    European Journal of Biochemistry, 251 (03):
  • [23] Delayed ontogenesis of CYP1A2 in the human liver
    Sonnier, M
    Cresteil, T
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (03): : 893 - 898
  • [24] Uroporphyria in mice: Thresholds for hepatic CYP1A2 and iron
    Gorman, N
    Ross, KL
    Walton, HS
    Bement, WJ
    Szakacs, JG
    Gerhard, GS
    Dalton, TP
    Nebert, DW
    Eisenstein, RS
    Sinclair, JF
    Sinclair, PR
    HEPATOLOGY, 2002, 35 (04) : 912 - 921
  • [25] Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice
    Powley, MW
    Carlson, GP
    TOXICOLOGY, 2001, 169 (03) : 187 - 194
  • [26] Olanzapine metabolism by CYP1A2/CYP2D6 and hyperglycaemia
    Iwahashi, K
    ACTA NEUROPSYCHIATRICA, 2004, 16 (04) : 229 - 230
  • [27] The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
    Eiermann, B
    Engel, G
    Johansson, I
    Zanger, UM
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 439 - 446
  • [28] Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats
    Gao, Na
    Qi, Bing
    Liu, Fang-jun
    Fang, Yan
    Zhou, Jun
    Jia, Lin-jing
    Qiao, Hai-ling
    PLOS ONE, 2014, 9 (02):
  • [29] Metabolism of the antiandrogenic drug (flutamide) by human CYP1A2
    Shet, MS
    Mcphaul, M
    Fisher, CW
    Stallings, NR
    Estabrook, RW
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (11) : 1298 - 1303
  • [30] Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes
    Kot, Marta
    Daniel, Wladyslawa A.
    PHARMACOLOGICAL REPORTS, 2009, 61 (06) : 1216 - 1220